These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 16276579)
1. If you build it, they will pay. A novel incentive called and Advance Market Commitment could help spur private sector investment in AIDS vaccine research and development. Zandonella C IAVI Rep; 2005; 9(3):13, 18-21. PubMed ID: 16276579 [No Abstract] [Full Text] [Related]
2. Private investment in AIDS vaccine development: obstacles and solutions. Batson A; Ainsworth M Bull World Health Organ; 2001; 79(8):721-7. PubMed ID: 11545328 [TBL] [Abstract][Full Text] [Related]
3. Private sector needs incentives for AIDS vaccine. Irvine B BMJ; 2004 Oct; 329(7472):979. PubMed ID: 15499127 [No Abstract] [Full Text] [Related]
4. Fundraising 101: why seek private funding? Duyck GP J Public Health Manag Pract; 2008; 14(2):199-201. PubMed ID: 18287928 [No Abstract] [Full Text] [Related]
5. Global health public-private partnerships: IAVI, partnerships and capacity building. Hanlin R; Chataway J; Smith J Afr J Med Med Sci; 2007; 36 Suppl():69-75. PubMed ID: 17703568 [TBL] [Abstract][Full Text] [Related]
6. New public private partnerships for AIDS vaccine development. IAVI Rep; 2005; 9(5):20. PubMed ID: 16541504 [No Abstract] [Full Text] [Related]
7. A firm response to AIDS. Nature; 2006 Oct; 443(7113):738-9. PubMed ID: 17051178 [No Abstract] [Full Text] [Related]
8. Are private dollars for research shifting diseases? Miller M J Natl Cancer Inst; 2001 Feb; 93(4):264-5. PubMed ID: 11181772 [No Abstract] [Full Text] [Related]
9. A new era in HIV vaccine development. Lau CY; Velasco PP; Johnston MI Expert Rev Anti Infect Ther; 2007 Apr; 5(2):205-15. PubMed ID: 17402836 [TBL] [Abstract][Full Text] [Related]
10. Chapter 26: Innovative financing mechanisms to accelerate the introduction of HPV vaccines in developing countries. Batson A; Meheus F; Brooke S Vaccine; 2006 Aug; 24 Suppl 3():S3/219-25. PubMed ID: 16950010 [TBL] [Abstract][Full Text] [Related]
11. Market incentives, human lives, and AIDS vaccines. Craddock S Soc Sci Med; 2007 Mar; 64(5):1042-56. PubMed ID: 17113203 [TBL] [Abstract][Full Text] [Related]
12. Human versus HIV: round 2 defeat in AIDS vaccine development. Lu S Expert Rev Vaccines; 2008 Mar; 7(2):151-3. PubMed ID: 18324884 [No Abstract] [Full Text] [Related]
13. Estimating the demand for a preventive HIV vaccine: why we need to do better. Reliable estimates would help in achieving several policy and advocacy objectives. Hecht R; Suraratdecha C PLoS Med; 2006 Sep; 3(10):e398. PubMed ID: 16953657 [TBL] [Abstract][Full Text] [Related]
14. Is private good enough? Mulrine A US News World Rep; 2004 Apr; 136(12):56. PubMed ID: 15095666 [No Abstract] [Full Text] [Related]
15. Investing Wisely in Health Care Capital. Klein DJ; Brown AD; Detsky AS JAMA; 2016 Oct; 316(15):1543-1544. PubMed ID: 27684645 [No Abstract] [Full Text] [Related]
17. Everyone wants to help the uninsured, but who will pay the bill? Why a national lottery may make sense. Cibley JM; Love D; Love LG Health Care Manag (Frederick); 2009; 28(4):311-9. PubMed ID: 19910707 [TBL] [Abstract][Full Text] [Related]
18. Public-private partnerships for equity of access to care for tuberculosis and HIV/AIDS: lessons from Pune, India. Sheikh K; Porter J; Kielmann K; Rangan S Trans R Soc Trop Med Hyg; 2006 Apr; 100(4):312-20. PubMed ID: 16438997 [TBL] [Abstract][Full Text] [Related]
19. Fund-raising. Musicians to provide hope to AIDS orphans. AIDS Policy Law; 2005 Apr; 20(7):1. PubMed ID: 15880855 [No Abstract] [Full Text] [Related]
20. Yours for the asking. Panas J J Natl Assoc Hosp Dev; 1986; ():7-8, 10-1. PubMed ID: 10313612 [No Abstract] [Full Text] [Related] [Next] [New Search]